1 Department of Ophthalmology, Yueqing Affiliated Hospital of Wenzhou Medical University, Wenzhou 325600, China 2 Zhongshan Ophthalmic Center of Zhongshan College, Guangzhou 510060, China
Objective: To identify potential laboratory risk factors for diabetic retinopathy (DR) among diabetic patients. Methods: In this hospital-based, cross-sectional comparative study, all diabetic inpatients at the endocrinology department, Yueqing Affiliated Hospital of Wenzhou Medical University from July 2013 to June 2015 were included. The fundus images of all participants after mydriasis was taken for the assessment of DR. Based on the fundus condition, the patients were divided into a DR group and a no-DR group. A t-test and Chi-square test were used for the comparison between the laboratory findings of the two groups.The potential risk factors of DR were evaluated by multiple logistic regression. Results: A total of 426 patients were enrolled in our study. Mean age of the participants was 64.5±11.0. There were 223 patients with diabetic retinopathy and 203 patients without diabetic retinopathy, based on a fundus assessment by the ETDRSsystem. After multiple regression analysis, it was found that higher levels of fasting blood glucose (OR=1.08, P=0.014), hemoglobin Alc (HbA1C) (OR=1.15, P=0.004), monocyte (OR=4.02, P=0.014), and proteinuria (OR=2.15, P=0.014) were positive correlation factor of DR. While higher levels of postprandial 2 hr C-peptide (OR=0.92, P=0.047), albumin (OR=0.92, P=0.001), mean corpuscular hemoglobin (MCH) (OR=0.88, P=0.030) and mean corpuscular volume (MCV) (OR=0.93, P=0.004) were negative correlation factor of DR. Conclusion: Our study show that some laboratory indexes are associated with the presence of DR and may be a risk factor for DR. More studies are needed to investigate the causal relationships and mechanisms.
Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract, 2017, 128: 40-50. DOI: 10.1016.diabres.2017.03.024.
[2]
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract, 2010, 87(1): 4-14. DOI: 10.1016.diabres.2009.10.007.
[3]
Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond), 2015, 2: 17. DOI: 10.1186/s40662-015-0026-2.
[4]
Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 2012, 35(3): 556-564. DOI: 10.2337/dc11-1909.
[5]
Zhang G, Chen H, Chen W, et al. Prevalence and risk factors for diabetic retinopathy in China: A multi-hospital-based crosssectional study. Br J Ophthalmol, 2017, 101(12): 1591-1595. DOI: 10.1136/bjophthalmol-2017-310316.
[6]
Hermann JM, Hammes HP, Rami-Merhar B, et al. HbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: A German/Austrian multicenter analysis on 35, 891 patients. PLoS One, 2014, 9(3): e91137. DOI: 10.1371/ journal.pone.0091137.
[7]
Traveset A, Rubinat E, Ortega E, et al. Lower hemoglobin concentration is associated with retinal ischemia and the severity of diabetic retinopathy in type 2 diabetes. J Diabetes Res, 2016, 2016: 3674946. DOI: 10.1155/2016/3674946.
[8]
Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care, 2004, 27(1): 216-222. DOI: 10.2337/diacare.27.1.216 .
[9]
Kastelan S, Tomic M, Gverovic Antunica A, et al. Body mass index: A risk factor for retinopathy in type 2 diabetic patients. Mediators Inflamm, 2013, 2013: 436329. DOI: 10.1155/2013/ 436329.
[10]
Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology, 1991, 98(5 Suppl): 786-806.
[11]
Bhatt MP, Lim YC, Ha KS. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy. Cardiovasc Res, 2014, 104(2): 234-244. DOI: 10.1093/cvr/ cvu211.
[12]
Chung JO, Cho DH, Chung DJ, et al. Relationship between serum C-peptide level and diabetic retinopathy according to estimated glomerular filtration rate in patients with type 2 diabetes. J Diabetes Complications, 2015, 29(3): 350-355. DOI: 10.1016/j.jdiacomp.2014.12.013.
[13]
Jee D, Lee WK, Kang S. Prevalence and risk factors for diabetic retinopathy: The Korea National Health and Nutrition Examination Survey 2008-2011. Invest Ophthalmol Vis Sci, 2013, 54(10): 6827-6833. DOI: 10.1167/iovs.13-12654.
[14]
Iwasaki T, Togashi Y, Terauchi Y. Significant association of serum albumin with severity of retinopathy and neuropathy, in addition to that of nephropathy, in Japanese type 2 diabetic patients. Endocr J, 2008, 55(2): 311-316. DOI: 10.1507/endocrj. k07-086.
[15]
Trevisan R, Vedovato M, Mazzon C, et al. Concomitance of diabetic retinopathy and proteinuria accelerates the rate of decline of kidney function in type 2 diabetic patients. Diabetes Care, 2002, 25(11): 2026-2031. DOI: 10.2337/diacare.25.11. 2026.
[16]
Qiao Q, Keinanen-Kiukaanniemi S, Laara E. The relationship between hemoglobin levels and diabetic retinopathy. J Clin Epidemiol, 1997, 50(2): 153-158.
[17]
Conway BN, Miller RG, Klein R, et al. Prediction of proliferative diabetic retinopathy with hemoglobin level. Arch Ophthalmol, 2009, 127(11): 1494-1499. DOI: 10.1001/ archophthalmol.2009.274.
[18]
Irace C, Scarinci F, Scorcia V, et al. Association among low whole blood viscosity, haematocrit, haemoglobin and diabetic retinopathy in subjects with type 2 diabetes. Br J Ophthalmol, 2011, 95(1): 94-98. DOI: 10.1136/bjo.2009.172601.
[19]
Min D, Brooks B, Wong J, et al. Alterations in monocyte CD16 in association with diabetes complications. Mediators Inflamm, 2012, 2012: 649083. DOI: 10.1155/2012/649083. [20] Wang W, He M, Huang W. Association of monocyte chemoattractant protein-1 gene 2518A/G polymorphism with diabetic retinopathy in type 2 diabetes mellitus: A meta-analysis. Diabetes Res Clin Pract, 2016, 120: 40-46. DOI: 10.1016/ j.diabres.2016.07.016.
[21]
Zhou Y, Zhang Y, Shi K, et al. Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review. Medicine (Baltimore), 2017, 96(22): e6754. DOI: 10.1097/MD. 0000000000006754.
[22]
Zheng Y, Lamoureux EL, Lavanya R, et al. Prevalence and risk factors of diabetic retinopathy in migrant Indians in an urbanized society in Asia: The Singapore Indian Eye Study. Ophthalmology, 2012, 119(10): 2119-2124. DOI: 10.1016/j. ophtha.2012.04.027.
[23]
Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia, 2001, 44(2): 156-163. DOI: 10.1007/s001250051594.